Kelly Pharmaceuticals Private Limited, a active private limited company, was established on 25 April 2018 in Uttam Nagar,New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909DL2018PTC333086. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Abdul Kadir (Director), Niti Kumar Choubey (Managing Director). Past directors included Nishi Kumari. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O- Vimlesh Dubey S/O- Ram Adhar,A-36,Deepak Vihar, Uttam Nagar,New Delhi, Delhi, 110059.
U51909DL2018PTC333086
333086
25 April 2018
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Kelly Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abdul Kadir | Director | 02 Feb 2022 | Current |
| Niti Kumar Choubey | Managing Director | 25 Apr 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kelly Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 89.86% increase. The company also saw a substantial improvement in profitability, with a 48.22% increase in profit. The company's net worth Soared by an impressive increase of 25.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Kelly Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kelly Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kelly Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kelly Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kelly Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Kelly Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Abdul Kadir was appointed as a Director was appointed as a Director on 02 Feb 2022 & has been associated with this company since 3 years 10 months . was completed.
Niti Kumar Choubey was appointed as a Managing Director was appointed as a Managing Director on 25 Apr 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.
The activity Kelly Pharmaceuticals Private Limited was registered on 25 Apr 2018 with Roc Delhi & aged 7 years 7 months as per MCA records. was completed.
The CIN of Kelly Pharmaceuticals Private Limited is U51909DL2018PTC333086.
Kelly Pharmaceuticals Private Limited is headquartered at C/O- Vimlesh Dubey S/O- Ram Adhar,A-36,Deepak Vihar, Uttam Nagar,New Delhi, Delhi, 110059.
Kelly Pharmaceuticals Private Limited was incorporated on 25 April 2018.
The current directors of Kelly Pharmaceuticals Private Limited are
The primary industry of Kelly Pharmaceuticals Private Limited is Trade.
Kelly Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kelly Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX